Construction of recombinant Mip-FlaA dominant epitope vaccine against Legionella pneumophila and evaluation of the immunogenicity and protective immunity

详细信息    查看全文

• 作者：Jinlei He ; Junrong Zhang ; Yanxia He ; Fan Huang ; Jiao Li ; Qiwei Chen…
• 关键词：Legionella pneumophila ; Epitope vaccine ; Mip ; FlaA ; Immunity
• 刊名：Immunologic Research
• 出版年：2016
• 出版时间：February 2016
• 年：2016
• 卷：64
• 期：1
• 页码：272-279
• 全文大小：5,419 KB
• 参考文献：1.Cianciotto NP. Pathogenicity of Legionella pneumophila. Int J Med Microbiol. 2001;291:331–43.CrossRef PubMed
  2.Fields BS, Benson RF, Besser RE. Legionella and legionnaires’ disease: 25 years of investigation. Clin Microbiol Rev. 2002;15:506–26.PubMedCentral CrossRef PubMed
  3.Gomez-Valero L, Rusniok C, Rolando M, Neou M, Dervins-Ravault D, Demirtas J, Rouy Z, Moore RJ, Chen H, Petty NK, Jarraud S, Etienne J, Steinert M, Heuner K, Gribaldo S, Médigue C, Glöckner G, Hartland EL, Buchrieser C. Comparative analyses of Legionella species identifies genetic features of strains causing Legionnaires’ disease. Genome Biol. 2014;15:505.PubMedCentral PubMed
  4.Ditommaso S, Giacomuzzi M, Rivera SR, Raso R, Ferrero P, Zotti CM. Virulence of Legionella pneumophila strains isolated from hospital water system and healthcare-associated Legionnaires’ disease in Northern Italy between 2004 and 2009. BMC Infect Dis. 2014;14:483.PubMedCentral CrossRef PubMed
  5.Disis ML, Gad E, Herendeen DR, Lai VP, Park KH, Cecil DL, O’Meara MM, Treuting PM, Lubet RA. A multi-antigen vaccine targeting neu, IGFBP-2 and IGF-IR prevents tumor progression in mice with pre-invasive breast disease. Cancer Prev Res (Phila). 2013;6:10.CrossRef
  6.Thera MA, Plowe CV. Vaccines for malaria: how close are we? Annu Rev Med. 2012;63:345–57.PubMedCentral CrossRef PubMed
  7.Rasch J, Theuerkorn M, Ünal C, Heinsohn N, Tran S, Fischer G, Weiwad M, Steinert M. Novel cycloheximide derivatives targeting the moonlighting protein mip exhibit specific antimicrobial activity against Legionella pneumophila. Front Bioeng Biotechnol. 2015;3:41.PubMedCentral CrossRef PubMed
  8.Ünal C, Schwedhelm KF, Thiele A, Weiwad M, Schweimer K, Frese F, Fischer G, Hacker J, Faber C, Steinert M. Collagen IV-derived peptide binds hydrophobic cavity of Legionella pneumophila Mip and interferes with bacterial epithelial transmigration. Cell Microbiol. 2011;13:1558–72.CrossRef PubMed
  9.Ricci ML, Torosantucci A, Scaturro M, Chiani P, Baldassarri L, Pastoris MC. Induction of protective immunity by Legionella pneumophila flagellum in an A/J mouse model. Vaccine. 2005;23:4811–20.CrossRef PubMed
  10.Hadler SC, Castro KG, Dowdle W, Hicks L, Noble G, Ridzon R. Epidemic intelligence service investigations of respiratory illness, 1946–2005. Am J Epidemiol. 2011;174:S36–46.CrossRef PubMed
  11.Sharon J, Rynkiewicz MJ, Lu Z, Yang CY. Discovery of protective B-cell epitopes for development of antimicrobial vaccines and antibody therapeutics. Immunology. 2014;142:1–23.PubMedCentral CrossRef PubMed
  12.Oyarzun P, Kobe B. Computer-aided design of T-cell epitope-based vaccines: addressing population coverage. Int J Immunogenet. 2015;42:313–21.CrossRef PubMed
  13.Xu M, Zhou L, Zhang Y, Xie Z, Zhang J, Guo L, Wang C, Yang X. A fixed human umbilical vein endothelial cell vaccine with 2 tandem repeats of microbial HSP70 peptide epitope 407-426 as adjuvant for therapy of hepatoma in mice. J Immunother. 2015;38:276–84.CrossRef PubMed
  14.Delfani S, ImaniFooladi AA, Mobarez AM, Emaneini M, Amani J, Sedighian H. In silico analysis for identifying potential vaccine candidates against Staphylococcus aureus. Clin Exp Vaccine Res. 2015;4:99–106.PubMedCentral CrossRef PubMed
  15.Xu Y, Guan W, Xu JN, Cao DP, Yang BB, Chen DL, Chen JP. Evaluation of the protective immunity of the Legionella pneumophila recombinant protein FlaA/MompS/PilE in an A/J mouse model. Vaccine. 2011;29:4051–7.CrossRef PubMed
  16.Xu JN, Yang ZW, Chen JP, Chen DL, Wang T, Liu MJ, Zhang L, Yang BB. Protective immunity against Legionnaires’ disease in an A/J mouse model using a DNA vaccine composed of an outer membrane protein (29 kDa) and the PilE fusion protein. Diagn Microbiol Infect Dis. 2012;73:9–15.CrossRef PubMed
  17.Liu M, Conover GM, Isberg RR. Legionella pneumophila EnhC is required for efficient replication in tumour necrosis factor alpha-stimulated macrophages. Cell Microbiol. 2008;10:1906–23.PubMedCentral CrossRef PubMed
  18.Newton C, McHugh S, Widen R, Nakachi N, Klein T, Friedman H. Induction of interleukin-4 (IL-4) by legionella pneumophila infection in BALB/c mice and regulation of tumor necrosis factor alpha, IL-6, and IL-1beta. Infect Immun. 2000;68:5234–40.PubMedCentral CrossRef PubMed
  19.McCoy-Simandle K, Stewart CR, Dao J, DebRoy S, Rossier O, Bryce PJ, Cianciotto NP. Legionella pneumophila type II secretion dampens the cytokine response of infected macrophages and epithelia. Infect Immun. 2011;79:1984–97.PubMedCentral CrossRef PubMed
  20.Medzhitov R. Recognition of microorganisms and activation of the immune response. Nature. 2007;449:819–26.CrossRef PubMed
  21.Kimizuka Y, Kimura S, Saga T, Ishii M, Hasegawa N, Betsuyaku T, Iwakura Y, Tateda K, Yamaguchi K. Roles of interleukin-17 in an experimental Legionella pneumophila pneumonia model. Infect Immun. 2012;80:1121–7.PubMedCentral CrossRef PubMed
  22.Sun H, Ma H, Liu L, Cao X, Yang Z. A new ELISA method for serological diagnosis of Legionella pneumophila: use of five purified proteins, FLA, MOMP, MIP, IP, and PILE, as diagnostic antigen. Clin Lab. 2015;61:275–82.PubMed
  
• 作者单位：Jinlei He (1)
  Junrong Zhang (1)
  Yanxia He (1) (2)
  Fan Huang (3)
  Jiao Li (1)
  Qiwei Chen (1)
  Dali Chen (1)
  Jianping Chen (1) (4)
  
  1. Department of Parasitology, West China School of Preclinical and Forensic Medicine, Sichuan University, Chengdu, 610041, China
  2. Department of Pathogen Biology and Immunology, Medical College, Hubei University for Nationalities, Enshi, 445000, China
  3. First Department of Hepatobiliary Surgery, Qinghai University Affiliated Hospital, Medical College of Qinghai University, Xining, 810016, China
  4. Animal Disease Prevention and Food Safety Key Laboratory of Sichuan Province, School of Life Science, Sichuan University, Chengdu, 610041, China
  
• 刊物主题：Allergology; Immunology; Medicine/Public Health, general; Internal Medicine;
• 出版者：Springer US
• ISSN：1559-0755

文摘

Legionnaires’ disease, a kind of systemic disease with pneumonia as the main manifestation, is caused by Legionella pneumophila (L. pneumophila). In order to prevent the disease, we optimized Mip and FlaA, the virulence factors of L. pneumophila, to design recombinant Mip-FlaA dominant epitope vaccine against the pathogen. Firstly, the coding sequences of mip and flaA were optimized by DNAStar software and Expasy protein analysis system, and then, the tertiary structure and function of recombinant Mip-FlaA were predicted by PHYRE2 Protein Fold Recognition Server. After that, the optimized mip, flaA and mip-flaA were cloned, expressed and purified, and the proteins were used as dominant epitope vaccines to immunize BABL/c mice. Moreover, the IgG titers, histological changes in lung and the level of TNF-α, IFN-γ, IL-6 and IL-1β were detected to reflect the immunogenicity and protective immunity of the vaccines. The results of SDS-PAGE and Western blot proved the recombinant Mip-FlaA was successfully expressed. ELISA results of IgG titers and these cytokines showed Mip-FlaA group was capable to induce the strongest immune response, compared to PBS, Mip and FlaA groups. In addition, histopathology analysis demonstrated the mice immunized with Mip-FlaA showed better immune protection. Therefore, the work indicated that the above-described biological tools were useful in optimization of epitope vaccine. Antigenic characterization and immune protection of recombinant Mip-FlaA would be of great value in understanding the immunopathogenesis of the disease and in developing possible vaccine against the pathogen. Keywords Legionella pneumophila Epitope vaccine Mip FlaA Immunity